
Glimitab M 1 mg/500 mg Tablet
Marketer
Centaur Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Glimitab M 1 mg/500 mg Tablet
DiaBetaComb 1 mg/500 mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer DiaBetaComb with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar response. Continued use is crucial, even with well-managed blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are vital in diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to identify its symptoms (sweating, dizziness, headache, tremors) and appropriate countermeasures. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be limited due to its hypoglycemic risk. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. Contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease before commencing treatment; it may be unsuitable. Consult your physician before use during pregnancy or breastfeeding. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.
Uses of Glimitab M 1 mg/500 mg Tablet
Managing Type 2 Diabetes
Major Benefits of Glimitab M 1 mg/500 mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimitab M 1 mg/500 mg tablets should be administered with a meal.
Common Side effects of Glimitab M 1 mg/500 mg Tablet:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glimitab M 1 mg/500 mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimitab M 1 mg/500 mg tablets should be administered with a meal.
How Glimitab M 1 mg/500 mg Tablet works:
Glimitab M, a 1 mg/500 mg tablet, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimitab M 1 mg/500 mg Tablet with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Glimitab M 1 mg/500 mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against potential hazards before prescribing. Patient consultation with their doctor is advised.
Breast feedingUNSAFE
Lactation and Glimitab M 1 mg/500 mg tablets are incompatible. Evidence indicates potential infant harm from this medication.
DrivingCAUTION
Impaired driving is possible with excessively low or high blood glucose. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Glimitab M 1 mg/500 mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Glimitab M 1 mg/500 mg tablets are contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimitab M 1 mg/500 mg tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate hepatic dysfunction, a low initial dose is typically prescribed; however, Glimitab M 1 mg/500 mg tablets are contraindicated in cases of severe liver disease.
What if you forget to take Glimitab M 1 mg/500 mg Tablet :
Should you forget a Glimitab M 1 mg/500 mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimitab M 1 mg/500 mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
